LeafNLP Demos
Back to explore

Report #2885898

Received Feb 17, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
IL
Recovered
Unknown
Vaccinated
Jan 14, 2026
Onset
Jan 16, 2026
Days to onset
2
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1——

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Received Two Doses of Heplisav-B Within Two Days; Initial report received on 20-Jan-2026. A pharmacist reported that a female patient inadvertently received two doses of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization within two days. No medical history or concomitant medications were reported. On 14-Jan-1016, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 16-Jan-1016, two days after receiving the first dose of HEPLISAV-B, the patient received dose 2 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. The patient came to a different pharmacy from dose 1 and inadvertently received a second dose of HEPLISAV-B. The patient received the second dose within two days from the first. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.